Trials / Completed
CompletedNCT01559519
Post Transjugular Intrahepatic Portosystemic Shunt (Tips) Albumine Infusion to Prevent Hepatic Encephalopathy
Effect of Albumine Infusion in the Prevention of Hepatic Encephalopathy After Transjugular Intrahepatic Portosystemic Shunt
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 20 (actual)
- Sponsor
- University of Roma La Sapienza · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the efficacy of albumin infusion to prevent post tips hepatic encephalopathy'
Detailed description
The outcome is the prevention of post tips hepatic encephalopathy
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Albumin | albumin 20% 1 g/Kg body weight for the first two days after TIPS followed by 0,5 g/Kg body weight at day 4 and then 0,5 g/Kg body weight once a week for three weeks. |
Timeline
- Start date
- 2012-09-01
- Primary completion
- 2013-12-01
- Completion
- 2013-12-01
- First posted
- 2012-03-21
- Last updated
- 2013-12-17
Source: ClinicalTrials.gov record NCT01559519. Inclusion in this directory is not an endorsement.